Document Detail


Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
MedLine Citation:
PMID:  17945337     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The aim of this study was to evaluate the usefulness of integrated 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (PET/CT) for the detection of para-aortic nodal status and to test whether PET/CT change management strategy in locally advanced cervical cancer (LACC) patients with negative conventional CT findings. MATERIALS AND METHODS: Sixteen locally advanced (FIGO stage IIB-IVA) cervical squamous cancer patients with negative conventional CT findings were eligible to enter this prospective study. All patients underwent firstly PET/CT scans then extraperitoneal surgical exploration for para-aortic lymphadenectomy. Based on histopathologic confirmation, the accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the PET/CT for para-aortic lymph node metastasis were estimated. RESULTS: The median age was 48.7 (range 42-67). The accuracy, sensitivity, specificity, PPV and NPV of the PET/CT were 75%, 50%, 83.3%, 50% and 83.3%, respectively. The treatment was modified in four of sixteen (25%) patients; four patients received EFRT in combination with cisplatin chemotherapy instead of standard pelvic field radiotherapy in combination with cisplatin chemotherapy. CONCLUSION: Our results, despite our study group is small, suggest that PET/CT is an effective imaging technique in the evaluation of LACC with negative CT findings. It may help planning the management especially selecting radiation field. However, larger controlled studies are needed to recommend PET/CT as an alternative to pre-treatment surgical staging.
Authors:
Y Yildirim; S Sehirali; M E Avci; C Yilmaz; K Ertopcu; S Tinar; Y Duman; S Sayhan
Related Documents :
17701257 - Clinical practice guidelines for the utilization of positron emission tomography/comput...
19091887 - The effectiveness of 18f-fdg pet/ct combined with stir mri for diagnosing nodal involve...
17320577 - Advances in positron emission tomography technology have increased the need for surgica...
18647907 - The role of imaging in the diagnosis, staging, and management of testicular cancer.
9639957 - Pleural fluid: accuracy of computed tomography in differentiating exudates from transud...
15374537 - The use of mutual information in registration of ct and mri datasets post permanent imp...
Publication Detail:
Type:  Journal Article     Date:  2007-10-22
Journal Detail:
Title:  Gynecologic oncology     Volume:  108     ISSN:  1095-6859     ISO Abbreviation:  Gynecol. Oncol.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2007-12-31     Completed Date:  2008-01-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0365304     Medline TA:  Gynecol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  154-9     Citation Subset:  IM    
Affiliation:
Department of Gynecologic Oncology, Aegean Obstetrics and Gynecology Training and Research Hospital, Izmir, Turkey. dr.yusufyildirim@yahoo.com.tr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
CA-125 Antigen / blood
Female
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Lymph Nodes / radionuclide imaging*
Lymphatic Metastasis
Middle Aged
Neoplasm Recurrence, Local / blood,  pathology,  radionuclide imaging*
Neoplasm Staging
Positron-Emission Tomography
Prospective Studies
Radiopharmaceuticals / diagnostic use*
Tomography, X-Ray Computed
Uterine Cervical Neoplasms / blood,  pathology,  radionuclide imaging*
Chemical
Reg. No./Substance:
0/CA-125 Antigen; 0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma:...
Next Document:  Alpha-2 agonists decrease expression of morphine-induced conditioned place preference.